Aneurysm Clips Market (2026 - 2033)

Aneurysm Clips Market Summary

The global aneurysm clips market size was valued at USD 79.2 million in 2025 and is projected to grow from USD 85.0 million in 2026 to USD 139.8 million in 2033, at a CAGR of 7.4% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 26.0% in 2025. The rising incidence of laparoscopic surgical procedures and the use of highly appropriate materials, including stainless steel alloys, pure titanium, titanium alloy, Elgiloy, and Phynox in aneurysm clips, are the factors promoting market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

In addition, the market is expected to be driven by a rising geriatric population, rising incidence of intracranial aneurysm ruptures, and the accessibility of biocompatible aneurysm clips in various sizes and shapes. The global market for aneurysm clips is experiencing rapid technological advancements in portability and miniaturization, such as clip appliers and tipsters, which can be used endoscopically or laparoscopically without making significant incisions on a patient’s body surface. For instance, B. Braun's YASARGIL aneurysm clips are available in MRI-safe titanium and Phynox variants and are offered in a broad range of clip designs and appliers, enabling neurosurgeons to treat complex aneurysm anatomies with greater precision and procedural flexibility.

A rise in the prevalence of neurological disorders, such as cerebral aneurysms, epilepsy, and strokes, in several countries is expected to fuel market growth. Cerebral aneurysms are increasingly detected due to the growing use of advanced neuroimaging technologies and greater awareness of cerebrovascular diseases. According to the Brain Aneurysm Foundation, approximately 6.8 million people in the United States are estimated to have an unruptured brain aneurysm, representing about 1 in 50 individuals. In addition, around 30,000 people in the U.S. experience a brain aneurysm rupture each year. The increasing prevalence of risk factors such as hypertension, smoking, and excessive alcohol consumption contributes to the occurrence of cerebral aneurysms, thereby supporting demand for aneurysm clipping procedures and associated devices.

Furthermore, high cholesterol, diabetes, cigarette smoking, and high blood pressure increase the risk of atherosclerosis and cerebral aneurysm rupture. According to the World Health Organization, an estimated 1.4 billion adults aged 30–79 years worldwide have hypertension, a major risk factor for intracranial aneurysm development and rupture. The growing burden of hypertension and other lifestyle-related disorders is expected to increase the incidence of aneurysms globally, supporting the demand for aneurysm clips and neurosurgical interventions.

Market Dynamics

The market is experiencing steady growth, driven by the rising prevalence of intracranial aneurysms, the increasing incidence of cerebrovascular disorders, and the growing adoption of advanced neurosurgical procedures. Improved diagnostic capabilities through MRI, CT angiography (CTA), and magnetic resonance angiography (MRA) are enabling earlier detection of both ruptured and unruptured aneurysms, thereby increasing the number of patients eligible for surgical intervention. In addition, technological advancements in MRI-compatible titanium clips, low-artifact clip designs, and precision microsurgical instruments are improving treatment outcomes and encouraging adoption across hospitals and neurosurgical centers. Growing healthcare expenditure, expansion of neurosurgical infrastructure, and increasing awareness of stroke prevention further support market growth.

Analyst Perspective

The market sits at the intersection of several long-term growth drivers, including the rising prevalence of intracranial aneurysms, the growing burden of cerebrovascular diseases, and ongoing advances in neurosurgical technologies. As healthcare systems expand access to specialized neurovascular care and adopt advanced imaging modalities for earlier diagnosis, the number of patients eligible for aneurysm intervention is expected to increase steadily. The competitive advantage will increasingly favor manufacturers that combine innovative clip designs, MRI compatibility, surgical precision, and integration with advanced visualization and microsurgical platforms. As treatment outcomes and procedural efficiency become key priorities for healthcare providers, companies offering comprehensive, technologically advanced aneurysm-clipping solutions will be best positioned to capture long-term market growth.

Material Insights

The titanium aneurysm clip segment dominated the market with approximately 82.0% market share in 2025 and is anticipated to grow at the highest CAGR in the forecast period. The features of titanium aneurysm clips include inertness, durability, high tensile strength, nonreactivity, and light weight. The compatibility with imaging modalities, namely MRI, CT, and X-rays, along with its ability to secure the closure of delicate vessels during procedures, makes it a preferred option as surgical equipment, thereby driving the segment growth. Furthermore, compared to other materials, titanium aneurysm clips have minimal interference with MRI and CT (tomography) scans.

According to the Brain Aneurysm Foundation, titanium clips are generally preferred because they are MRI-compatible and do not trigger metal detector alarms. In the field of medical equipment, titanium and its alloys are widely used due to their high biocompatibility. According to an article published by Medical Device News Magazine in September 2024, researchers from Kyungpook National University developed and evaluated a novel ceramic aneurysm clip integrated with a titanium spring. The study demonstrated that the titanium-based design provided reliable closing force, enhanced durability, and superior MRI compatibility with reduced imaging artifacts compared to conventional titanium alloy clips.

Indication Insights

The stroke segment dominated the market with a share of over 57.0% in 2025, owing to factors such as rising stroke prevalence, hypertension, and various other neurological disorders. According to the World Stroke Organization, stroke remains one of the leading causes of death and long-term disability worldwide, with more than 12 million new stroke cases occurring annually and over 100 million people living with the effects of stroke globally. The growing burden of stroke, particularly among aging populations and individuals with hypertension, diabetes, and cardiovascular diseases, continues to drive demand for neurovascular interventions, including aneurysm clipping procedures.

The cerebral aneurysm segment is anticipated to grow at the highest CAGR during the forecast period, primarily due to the rising incidence of intracranial aneurysms. Moreover, increasing demand for minimally invasive neurosurgical procedures and the adoption of advanced surgical technologies are supporting segment growth. Furthermore, growing clinical evidence continues to support the effectiveness of microsurgical clipping in achieving durable aneurysm occlusion. For instance, a 2024 international study published in the journal Neurosurgery established global benchmarks for outcomes following microsurgical clipping of unruptured intracranial aneurysms, highlighting the procedure's continued importance in aneurysm management and reinforcing demand for aneurysm clips in specialized neurosurgical centers.

End Use Insights

The hospital segment dominates the aneurysm clip market, accounting for approximately 66.0% of revenue in 2025. This is attributed to the rising number of surgical procedures, such as abdominal and neurosurgical laparoscopy, and the growing frequency of trauma. In developed countries, insurance companies pay for medical expenditures, including ligature costs. The rise in surgical procedures performed in hospitals equipped with clipping equipment has, as a result, a favorable effect on the segment's growth.

Ambulatory surgical centers (ASCs) are expected to have the highest CAGR during the forecast period. This can be attributed to lower out-of-pocket expenses, reduced facility costs, and better patient accessibility. Most of the Middle Eastern and Asian countries still lack the economic or infrastructure capacity to establish ambulatory centers; however, they are working towards this goal to minimize the burden of surgical operations in hospitals. In addition, ongoing advancements in minimally invasive neurosurgical techniques and improvements in perioperative care are enabling more procedures to be performed in outpatient settings, further supporting the adoption of ambulatory surgical centers for neurovascular interventions.

Regional Insights

North America dominated the aneurysm clips market, accounting for over 26.0% of revenue in 2025. The rising prevalence of neurological disorders and the increasing demand for minimally invasive surgical procedures are driving market growth in this region. For instance, according to the CDC, in the US, more than 795,000 people suffer from stroke, with 87% identified as ischemic stroke.

To learn more about this report, Download Free Sample Report

U.S. Aneurysm Clips Market Trends

The aneurysm clips market in the U.S. is growing significantly as an increasing number of initiatives are undertaken by various organizations. For instance, the Bee Foundation (TBF), a nonprofit organization, focuses on raising awareness and reducing deaths from cerebral aneurysms through innovative research. In September 2025, the Brain Aneurysm Foundation launched awareness initiatives during Brain Aneurysm Awareness Month to promote early diagnosis, patient education, and research funding for cerebral aneurysm treatment. Such initiatives are expected to support the adoption of neurovascular treatment procedures nationwide.

Asia Pacific Aneurysm Clips Market Trends

The aneurysm clips market in the Asia Pacific is anticipated to witness the fastest growth rate over the forecast period owing to factors such as the rising target disease burden, growing geriatric population, rising unhealthy lifestyle among youngsters, and increasing incidence of acute ischemic stroke. According to the Asian Development Bank's 2026 policy brief, Turning the Tide on Stroke in Asia and the Pacific, the Asia-Pacific region accounts for more than half of the global stroke burden. The increasing prevalence of cerebrovascular diseases across major countries such as China and India is expected to drive demand for aneurysm diagnosis and neurovascular interventions, supporting market growth in the region. In addition, emerging economies such as China, South Korea, and India are expected to witness considerable growth over the forecast period. Furthermore, the establishment of organizations such as the Asia-Pacific Center for Neuromodulation (APCN), founded to conduct research and raise awareness of the benefits of deep brain stimulation surgeries, is anticipated to boost market growth.

Key Aneurysm Clips Company Insights

Companies are focusing on developing novel medical devices, expanding, and pursuing technological innovations. Moreover, mergers and acquisitions for new product development and strengthening supply chain networks are among the strategic initiatives implemented by major players.

Key Aneurysm Clips Companies Insights

The following key companies have been profiled for this study on the aneurysm clips market:

• Aesculap, Inc. - a B. Braun company
• Rebstock Instruments GmbH
• Mizuho
• Adeor Medical AG
• Integra LifeSciences Corporation
• Lazic GmbH
• KLS Martin Group
• Shenzhen YKD Technology Co., Ltd.
• NARISHIGE Group
• Medicon eG.

Recent Developments

• In September 2025, B. Braun SE acquired True Digital Surgery, a specialist in robotic-assisted 3D digital microscopy. The acquisition strengthened B. Braun’s Aesculap neurosurgery portfolio and expanded its capabilities in advanced microsurgical visualization technologies used in neurosurgical and cerebrovascular procedures, including aneurysm clipping.

• In September 2024, Integra LifeSciences Corporation Holdings Corporation announced the acquisition of Acclarent from Johnson & Johnson for approximately USD 275 million. The acquisition expanded Integra’s portfolio of surgical technologies and strengthened its position in specialty surgical markets, supporting the company’s broader neurosurgery and cranial care business segments.

Global Aneurysm Clips Market Segments

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global aneurysm clips market based on material, indication, end use, and region:

• Material Outlook (Revenue, USD Million, 2021 - 2033)

  • Titanium Aneurysm Clips

  • Polymer

  • Others

• Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Stroke

  • Cerebral Artery Stenosis

  • Cerebral Aneurysm

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Ambulatory Surgical Centers

  • Others (Clinics, Neurology Centers)

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait